Literature DB >> 2679552

Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activity.

J M Louis1, C A Smith, E M Wondrak, P T Mora, S Oroszlan.   

Abstract

The 297bp gene coding for the HIV-1 protease was chemically synthesized and expressed in E. coli. Single amino acid substitutions (Arg 87 - greater than Lys; Arg 87 - greater than Glu) were introduced in the C-terminally located conserved region GlyArgAsn of the protease gene in the wild-type clone. The products of the mutant and the wild-type clones were expressed at approximately similar levels at 30 minutes of induction but the mutant protease proteins accumulated as a function of time of induction unlike the wild-type protease which declined after 60 minutes. The mutants were completely devoid of proteolytic activity as determined in assays employing as substrates a synthetic nonapeptide and a gag related recombinant polyprotein.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2679552     DOI: 10.1016/0006-291x(89)91678-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Design of dimerization inhibitors of HIV-1 aspartic proteinase: a computer-based combinatorial approach.

Authors:  A Caflisch; H J Schramm; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

2.  A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389A.

Authors:  M L Smidt; K E Potts; S P Tucker; L Blystone; T R Stiebel; W C Stallings; J J McDonald; D Pillay; D D Richman; M L Bryant
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

3.  Interactions of different inhibitors with active-site aspartyl residues of HIV-1 protease and possible relevance to pepsin.

Authors:  Jane M Sayer; John M Louis
Journal:  Proteins       Date:  2009-05-15

4.  Autoprocessing: an essential step for the activation of HIV-1 protease.

Authors:  M Wan; M Takagi; B N Loh; X Z Xu; T Imanaka
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

5.  Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity.

Authors:  J R Rosé; L M Babé; C S Craik
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Dimer Interface Organization is a Main Determinant of Intermonomeric Interactions and Correlates with Evolutionary Relationships of Retroviral and Retroviral-Like Ddi1 and Ddi2 Proteases.

Authors:  János András Mótyán; Márió Miczi; József Tőzsér
Journal:  Int J Mol Sci       Date:  2020-02-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.